Production (Stage)
Evogene Ltd.
EVGN
$1.38
-$0.14-9.21%
NASDAQ
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -40.28% | 41.48% | -65.69% | -65.69% | 43.27% |
| Total Depreciation and Amortization | -8.64% | 1.21% | 0.30% | 0.30% | 2.16% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -84.68% | 274.18% | -208.87% | -208.87% | 105.43% |
| Change in Net Operating Assets | 58.24% | -425.93% | 138.71% | 138.71% | -248.39% |
| Cash from Operations | -32.73% | 30.63% | -37.25% | -37.25% | 15.20% |
| Capital Expenditure | 78.01% | -63.95% | 60.19% | 60.19% | -74.19% |
| Sale of Property, Plant, and Equipment | -100.00% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 176.60% | -746.20% | -112.95% | -112.95% | 149.64% |
| Cash from Investing | 173.59% | -644.37% | -116.08% | -116.08% | 146.13% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | -8.96% | -0.47% | -0.47% | -1.93% |
| Issuance of Common Stock | 2,666.67% | -93.33% | -99.44% | -99.44% | 11,764.71% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 97.84% | -795.00% | 134.48% | 134.48% | -100.55% |
| Cash from Financing | 58.86% | -149.66% | -101.88% | -101.88% | -25.35% |
| Foreign Exchange rate Adjustments | -94.44% | -118.18% | 453.57% | 453.57% | 87.44% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 72.55% | -35.04% | -192.41% | -192.41% | 356.52% |